Beavers Kristen M, Avery Allison E, Shankaran Mahalakshmi, Evans William J, Lynch S Delanie, Dwyer Caitlyn, Howard Marjorie, Beavers Daniel P, Weaver Ashley A, Lenchik Leon, Cawthon Peggy M
Department of Health and Exercise Science, Wake Forest University, Winston-Salem, North Carolina, USA.
University of California, Berkeley, California, USA.
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2350-2358. doi: 10.1002/jcsm.13322. Epub 2023 Sep 5.
Traditionally, weight loss (WL) trials utilize dual energy X-ray absorptiometry (DXA) to measure lean mass. This method assumes lean mass, as the sum of all non-bone and non-fat tissue, is a reasonable proxy for muscle mass. In contrast, the D -creatine (D Cr) dilution method directly measures whole body skeletal muscle mass, although this method has yet to be applied in the context of a geriatric WL trial. The purpose of this project was to (1) describe estimates of change and variability in D Cr muscle mass in older adults participating in an intentional WL intervention and (2) relate its change to other measures of body composition as well as muscle function and strength.
The INVEST in Bone Health trial (NCT04076618), used as a scaffold for this ancillary pilot project, is a three-armed, 12-month randomized, controlled trial designed to determine the effects of resistance training or weighted vest use during intentional WL on a battery of musculoskeletal health outcomes among 150 older adults living with obesity. A convenience sample of 24 participants (n = 8/arm) are included in this analysis. At baseline and 6 months, participants were weighed, ingested a 30 mg D Cr tracer dose, provided a fasted urine sample 3-6 days post-dosage, underwent DXA (total body fat and lean masses, appendicular lean mass) and computed tomography (mid-thigh and trunk muscle/intermuscular fat areas) scans, and performed 400-m walk, stair climb, knee extensor strength, and grip strength tests.
Participants were older (68.0 ± 4.4 years), mostly White (75.0%), predominantly female (66.7%), and living with obesity (body mass index: 33.8 ± 2.7 kg/m ). Six month total body WL was -10.3 (95% confidence interval, CI: -12.7, -7.9) kg. All DXA and computed tomography-derived body composition measures were significantly decreased from baseline, yet D Cr muscle mass did not change [+0.5 (95% CI: -2.0, 3.0) kg]. Of muscle function and strength measures, only grip strength significantly changed [+2.5 (95% CI: 1.0, 4.0) kg] from baseline.
Among 24 older adults, significant WL with or without weighted vest use or resistance training over a 6-month period was associated with significant declines in all bioimaging metrics, while D Cr muscle mass and muscle function and strength were preserved. Treatment assignment for the trial remains blinded; therefore, full interpretation of these findings is limited. Future work in this area will assess change in D Cr muscle mass by parent trial treatment group assignment in all study participants.
传统上,减肥(WL)试验利用双能X线吸收法(DXA)来测量瘦体重。该方法假定瘦体重作为所有非骨和非脂肪组织的总和,是肌肉量的合理替代指标。相比之下,D -肌酸(D Cr)稀释法直接测量全身骨骼肌质量,尽管该方法尚未应用于老年减肥试验。本项目的目的是:(1)描述参与有意减肥干预的老年人中D Cr肌肉质量的变化估计值和变异性;(2)将其变化与身体成分的其他测量指标以及肌肉功能和力量联系起来。
骨健康投资试验(NCT04076618)用作本辅助性试点项目的框架,是一项三臂、为期12个月的随机对照试验,旨在确定在150名肥胖老年人有意减肥期间进行抗阻训练或使用负重背心对一系列肌肉骨骼健康结局的影响。本分析纳入了24名参与者的便利样本(每组n = 8)。在基线和6个月时,对参与者进行称重,摄入30毫克D Cr示踪剂剂量,在给药后3 - 6天提供空腹尿液样本,进行DXA扫描(全身脂肪和瘦体重、四肢瘦体重)以及计算机断层扫描(大腿中部和躯干肌肉/肌间脂肪区域),并进行400米步行、爬楼梯、伸膝力量和握力测试。
参与者年龄较大(68.0 ± 4.4岁),大多为白人(75.0%),以女性为主(66.7%),且患有肥胖症(体重指数:33.8 ± 2.7 kg/m²)。6个月时全身减肥量为 -10.3(95%置信区间,CI:-12.7,-7.9)kg。所有DXA和计算机断层扫描得出的身体成分测量指标均较基线显著下降,但D Cr肌肉质量未发生变化[增加0.5(95% CI:-2.0,3.0)kg]。在肌肉功能和力量测量指标中,只有握力较基线有显著变化[增加2.5(95% CI:1.0,4.0)kg]。
在24名老年人中,6个月内无论是否使用负重背心或进行抗阻训练的显著减肥与所有生物成像指标的显著下降相关,而D Cr肌肉质量以及肌肉功能和力量得以保留。该试验的治疗分配仍处于盲态;因此这些发现的完整解读受到限制。该领域未来的工作将通过对所有研究参与者按母试验治疗组分配情况来评估D Cr肌肉质量的变化。